Skip to main content
. 2008 Aug 19;99(5):822–829. doi: 10.1038/sj.bjc.6604564

Table 3. Relative risks (RRs) of mortality for stripping/removal workers, using Poisson regression analyses.

  All causes
All MN
MN Trachea, bronchus & lung
  Cases RRa (95% CI) LR test (d.f.) Cases RRa (95% CI) LR test (d.f.) Cases RRa (95% CI) LR test (d.f.)
Main stripping method     4.03 (2)     2.35 (2)     2.71 (2)
 Wetc 397 1.0   141 1.0   48 1.0  
 Dry 409 1.1 (0.9–1.2)   169 1.2 (0.9–1.5)   39 0.8 (0.5–1.2)  
 Both 48 0.8 (0.6–1.1)   21 1.0 (0.6–1.6)   13 1.3 (0.7–2.7)  
Main respirator type     2.82 (6)   10.20 (6)       6.28 (6)
 Positive pressure maskc 664 1.0   245 1.0   70 1.0  
 Airstream helmet 4   1   1  
 Full face unpowered mask 127 1.0 (0.8–1.2)   55 1.1 (0.8–1.5)   16 1.1 (0.6–1.8)  
 Half face mask 18 0.8 (0.5–1.3)   4   1  
 Minimal 14 0.7 (0.4–1.3)   5   2  
 None 2   2   1  
 Mixed 51 1.1 (0.8–1.5)   25 1.4 (0.9–2.2)   11 1.7 (0.9–3.5)  
Weekly hours spent stripping     14.97 (4)**     1.00 (4)     0.87 (4)
 <10c 483 1.0   222 1.0   66 1.0  
  10− 74 1.0 (0.8–1.2)   32 1.0 (0.7–1.5)   8 0.9 (0.4–1.8)  
  20− 125 1.1 (0.9–1.4)   48 1.1 (0.8–1.5)   12 1.0 (0.5–1.8)  
  30− 124 1.3* (1.0–1.5)   33 0.9 (0.6–1.3)   9 0.9 (0.4–1.7)  
  40+ 163 1.4** (1.2–1.7)   44 1.0 (0.7–1.4)   15 1.2 (0.7–2.1)  
Smoking status   112.42 (2)**       41.07 (2)**     67.66 (2)**
 Never smokersc 118 1.0   38     1 1.0  
 Current smokers 622 2.5** (2.0–3.0)   216 1.0   86 43.0** (6.0–305.8)  
 Former smokers 225 1.5** (1.2–1.9)   125 2.8** (1.9–3.9)   26 16.0** (2.2–118.4)  
Age at first exposure (years)   14.80 (4)**       2.2** (1.5–3.1)     3.22 (4)
 <20c 184 1.0   91 1.0   21 1.0  
 20− 278 1.1 (0.9–1.3)   81 0.9 (0.7–1.2)   18 1.0 (0.5–1.8)  
 30− 193 0.9 (0.8–1.1)   70 0.8 (0.6–1.1)   23 1.2 (0.7–2.1)  
 40− 211 1.1 (0.9–1.3)   84 0.7* (0.5–1.0)   33 1.2 (0.7–2.0)  
 50+ 119 0.7** (0.6–0.9)   58 0.6** (0.4–0.8)   20 0.7 (0.4–1.3)  
Length of time in the survey     0.01 (1)     14.81 (1)**     5.13 (1)*
 Short-termc 419 1.0   116 1.0   33 1.0  
 Long-term 599 1.0 (0.9–1.1)   268 1.5** (1.2–1.9)   82 1.6* (1.1–2.4)  
Length of exposure (years)     16.29 (4)**     18.61 (4)**     6.88 (4)
 <10c 553 1.0   166 1.0   49 1.0  
 10− 161 1.0 (0.8–1.2)   60 1.1 (0.8–1.5)   26 1.6 (1.0–2.5)  
 20− 88 0.8 (0.7–1.0)   45 1.1 (0.8–1.5)   11 0.8 (0.4–1.6)  
 30− 94 1.0 (0.8–1.2)   61 1.4* (1.1–1.9)   14 1.0 (0.5–1.8)  
 40+ 89 1.5** (1.2–2.0)   52 2.1** (1.5–2.9)   15 1.7 (0.9–3.2)  
Time of first exposure     0.00 (1)     4.02 (1)*     1.43 (1)
 Pre-ALRc 430 1.0   217   1.0 66 1.0  
 Post-ALR 555 1.0 (0.9–1.1)   167   0.8* (0.7–1.0) 49 0.8 (0.5–1.2)  
  Mesotheliomab
Circulatory disease
Ischaemic heart disease
  Cases RRa (95% CI) LR test (d.f.) Cases RRa (95% CI) LR test (d.f.) Cases RRa (95% CI) LR test (d.f.)
Main stripping method     3.25 (2)     6.81 (2)*     8.61 (2)*
 Wetc 12 1.0   109 1.0   77 1.0  
 Dry 10 0.9 (0.4–2.1)   107 1.0 (0.7–1.3)   66 0.9 (0.6–1.2)  
 Both 0   7 0.4* (0.2–0.9)   3  
Main respirator type     10.14 (6)     1.54 (6)     2.24 (6)
 Positive pressure maskc 20 1.0   172 1.0   110 1.0  
 Airstream helmet 0   1   1  
 Full face unpowered mask 1   34 1.0 (0.7–1.4)   24 1.1 (0.7–1.7)  
 Half face mask 0   7 1.1 (0.5–2.5)   5  
 Minimal 0   4   2  
 None 1   0   0  
 Mixed 1   12 1.0 (0.5–1.7)   9 1.2 (0.6–2.3)  
Weekly hours spent stripping     2.29 (1)     12.34 (4)*     11.42 (4)*
 <10c 17 1.0   133 1.0   86 1.0  
 10− 6 0.5 (0.2–1.3)   16 0.8 (0.5–1.4)   12 1.0 (0.5–1.8)  
 20−     28 1.1 (0.7–1.6)   16 0.9 (0.6–1.6)  
 30−     32 1.4 (0.9–2.1)   24 1.6* (1.0–2.6)  
 40+     47 1.7** (1.2–2.4)   32 1.9** (1.2–2.8)  
Smoking status     2.27 (2)     33.41 (2)**     35.14 (2)**
 Never smokersc 5 1.0   38 1.0   19 1.0  
 Current smokers 7 0.7 (0.2–2.3)   161 2.1** (1.4–2.9)   114 2.9** (1.8–4.7)  
 Former smokers 11 1.5 (0.5–4.4)   53 0.9 (0.6–1.4)   34 1.2 (0.7–2.1)  
Age at first exposure (years)     22.12 (1)**     12.38 (4)*     12.71 (4)*
 <20c 14 1.0   44 1.0   33 1.0  
 20− 9 0.1** (0.1–0.3)   41 0.8 (0.5–1.2)   19 0.5* (0.3–0.9)  
 30−     51 1.0 (0.7–1.6)   34 0.9 (0.6–1.5)  
 40−     78 1.5* (1.0–2.2)   54 1.3 (0.9–2.1)  
 50+     44 0.9 (0.6–1.4)   31 0.9 (0.5–1.5)  
Length of time in the survey     8.23 (1)**     0.00 (1)     0.60 (1)
 Short-termc 3 1.0   102 1.0   72 1.0  
 Long-term 20 4.5* (1.3–16.0)   156 1.0 (0.8–1.3)   99 0.9 (0.6–1.2)  
Length of exposure (years)     18.59 (1)**     7.19 (4)     10.39 (4)*
 <10c     141 1.0   92 1.0  
 10−     48 1.0 (0.7–1.4)   36 1.2 (0.8–1.7)  
 20− 9d 1.0   27 0.8 (0.5–1.2)   14 0.6 (0.3–1.0)  
 30− 14 7.3** (2.5–21.6)   20 0.6* (0.4–0.9)   13 0.6* (0.3–1.0)  
 40+     22 0.9 (0.6–1.5)   16 1.1 (0.6–1.9)  
Time of first exposure     13.15 (1)**     0.46 (1)     0.84 (1)
 Pre-ALRc 19 1.0   123 1.0   81 1.0  
 Post-ALR 4   135 1.1 (0.8–1.4)   90 1.2 (0.8–1.6)  
  Cerebrovascular disease
Respiratory disease
     
  Cases RRa (95% CI) LR test (d.f.) Cases RRa (95% CI) LR test (d.f.)      
Main stripping method     0.62 (2)     2.46 (2)      
 Wetc 18 1.0   23 1.0        
 Dry 14 0.8 (0.4–1.5)   13 0.6 (0.3–1.2)        
 Both 2   4        
Main respirator type     7.12 (6)     4.02 (6)      
 Positive pressure maskc 31 1.0   33 1.0        
 Airstream helmet 0   0        
 Full face unpowered mask 4   4        
 Half face mask 0   0        
 Minimal 1   1        
 None 0   0        
 Mixed 0   3        
Weekly hours spent stripping     0.68 (2)     3.46 (3)      
 <10c 21 1.0   21 1.0        
 10− 10 1.4 (0.6–2.9)   8 1.1 (0.5–2.5)        
 30− 10 1.2 (0.6–2.7)   7 2.0 (0.8–4.6)        
 40+     8 1.9 (0.9–4.1)        
Smoking status     5.96 (2)     14.18 (2)**      
 Never smokersc 12 1.0   2 1.0        
 Current smokers 22 0.9 (0.4–1.8)   30 7.4** (1.8–30.6)        
 Former smokers 6 0.3* (0.1–0.9)   11 3.8 (0.8–17.2)        
Age at first exposure (years)     3.04 (4)     4.35 (3)      
 <20c 6 1.0   6 1.0        
 20− 8 1.1 (0.4–3.2)   12 1.7 (0.7–4.8)        
 30− 8 1.5 (0.5–4.7)   12 2.1 (0.8–5.3)        
 40− 12 2.2 (0.8–6.6)   14 1.0 (0.4–2.6)        
 50+ 7 1.3 (0.4–4.4)            
Length of time in the survey     0.45 (1)     0.46 (1)      
 Short-termc 15 1.0   20 1.0        
 Long-term 26 1.2 (0.7–2.3)   24 0.8 (0.5–1.5)        
Length of exposure (years)     0.94 (2)     7.14 (3)      
 <10c 24 1.0   25 1.0        
 10− 6 0.8 (0.3–1.9)   6 0.4 (0.2–1.1)        
 20− 11 0.7 (0.3–1.5)            
 30−     6 1.1 (0.4–2.7)        
 40+     7 1.9 (0.8–4.4)        
Time of first exposure     1.16 (1)     0.01 (1)      
 Pre-ALRc 18 1.0   22   1.0      
 Post-ALR 23 1.4 (0.7–2.8)   22 1.0 (0.5–1.8)        

*significant at P⩽0.05; **significant at P⩽0.01; LR test=Likelihood ratio test of goodness-of-fit; d.f.=degrees of freedom; CI=confidence interval.

a

Relative risk adjusted with Poisson regression for age, calendar period and sex.

b

ICD-10, post-2001.

c

Reference category.

d

Categories: <30, 30+.